Purpose
Third molar surgery is one of the most commonly performed operations, usually associated with high anxiety. The purpose of this study was to determine if patients' anxiety would reduce if consent was modified to match their dominant intelligence type (DIT).
Methods and materials
A single center, prospective randomized clinical study was conducted in the Maxillofacial Surgery Clinic of Ordu University on patients admitted for lower third molar removal between October 2020 and June 2021. The participants were randomly assigned to a study group where consent was based on DIT or a control group where consent was obtained in the standard fashion. DIT was determined using the multiple intelligence test and was further categorized as visual/spatial, verbal/linguistic, and bodily/kinesthetic. The consent method was the primary and the type of DIT was the secondary predictor variable. The primary and secondary outcome variables were the salivary cortisol level and Modified Dental Anxiety Scale (MDAS) scores measured before and after the consent, and after the operation. Mann-Whitney U, Friedman, Pearson correlation, and χ2tests were conducted for statistical analysis.
Results
Eighty patients (55 females and 25 males; mean age 23.5 ± 6.2) were included. No significant difference was observed between the study and control groups for the change in cortisol levels and MDAS scores before-after consent (−11.15 ± 62.64; −6.84 ± 32.9) (P = .389), −0.6 ± 3.46; −0.7 ± 2.49) (P = .832) and before consent-after operation (−39.80 ± 108.2; −39.72 ± 77.04) (P = .987), (−4.31 ± 5.97; −3 ± 4.34) (P = .867). The change in MDAS scores and cortisol levels was not correlated after consent (P = .587, r = 0.62) and operation (P = .406, r = 0.94).
Conclusion
Providing consent based on DIT is not statistically different than providing consent in the standard fashion. The role of consent strategy in managing anxiety and lack of correlation between salivary cortisol and MDAS requires further investigation.
Damla Torul, Mehmet Melih Omezli, Tolunay Avci, Ibrahim Selcuk Esin. "Does Modifying the Consent Process Based on the Dominant Intelligence Type Reduce Anxiety During 3rd Molar Operations?" Journal of Oral and Maxillofacial Surgery. March 01, 2023. DOI:https://doi.org/10.1016/j.joms.2023.02.015
Your website is your virtual storefront and, more often than not, a patient’s first impression of your practice.
Oral surgery 10 April 2026
A systematic literature search in MEDLINE, Embase, and the Guideline websites, from October 2007 to October 2012, produced articles that were critically evaluated.
The American Dental Association (ADA) recently commended Rep. Jeff Van Drew (R-NJ) and Rep. Herb Conaway (D-NJ), for introducing the Improving Dental Administration (IDA) Act to ensure that the more...
Oral Hygiene & Prevention 05 February 2026
Considerable controversy exists in the literature regarding the clinical course of young patients with oral squamous cell carcinoma (SCC).
Editorials 02 February 2026
When Erika Rezende Silva, DDS, enters the sound booth at Adams School of Dentistry’s Oral and Craniofacial Biomedicine Laboratory, she hears a familiar and personal story.
USA 26 July 2026 - 30 November -0001
American Academy of Periodontology Annual Meeting 2026: Event Preview and Professional Highlights
The American Academy of Periodontology Annual Meeting 2026 will take place from October 15, 2026 to October 18, 2026 in TBD, USA, offering dental professionals a focused environment for continuing...
Edra Professional Books 25 July 2026
Retreatments: A Clinical Reference for Contemporary Endodontic Practice
Retreatments is an Edra professional dentistry reference focused on clinical practice, education and treatment planning.
Products 24 July 2026
Expanded shade range supports fast, esthetic chairside zirconia restorations with 9-minute sintering when used with CEREC ® SpeedFire
News 24 July 2026
Sensei, a Carestream Dental brand and a global leader in dental practice management software and digital imaging solutions, today announced a strategic partnership with MAX Surgica
News 24 July 2026
Beach Point Capital Management LP (“Beach Point”), a global alternative investment manager with over $20 billion in assets under management, today announced the successful sale of